|
MAIN
Health
Diseases
Alzheimer's
Disease
Amyloid Plaques in Alzheimer's Disease Linked to Malfunction of Normal Memory Genes
The
buildup of Alzheimer's-associated amyloid plaques in the brain
dramatically inhibits several genes critical to memory and
learning, University of South Florida College of Medicine
researchers have found.
The strong link between the decreases
in select memory genes and amyloid accumulation was observed both in mice genetically engineered
to develop memory loss and in the brains of deceased Alzheimer's patients. The results were
reported in the June 15, 2003 issue of the Journal of Neuroscience.
"Blocking the ability of amyloid
to inhibit, or down-regulate, these genes may improve memory in patients with early Alzheimer's
disease," said principal investigator David Morgan, PhD, professor of pharmacology and
therapeutics and director of the Alzheimer's Disease Research Laboratory at USF.
Many experimental approaches to treating
Alzheimer's disease, including the vaccine, try to prevent the further formation of amyloid
plaques or remove some of them from the brain. But, Dr. Morgan said, by the time memory loss
becomes apparent the toxic plaques are probably accumulating too quickly to eliminate enough
amyloid needed to restore normal memory.
"Our study suggests a new approach
to treating this neurodegenerative disease that would enhance amyloid-lowering approaches,"
he said. "For instance, you might give a vaccine or some other immune therapy to reduce
the amyloid load and then start the patient on a memory-enhancing drug to block the effect
of any remaining amyloid on normal learning and memory."
"This interrogation of the genome
reveals new targets for both study and intervention," says D. Stephen Snyder, Ph.D.,
of the Etiology of Alzheimer's Disease-Cell Biology area of the National Institute on Aging,
which funded the research. "This study addresses the important question of what genes
related to learning and memory are regulated either up or down by amyloid."
Loss of recent memory is one of the first
symptoms of Alzheimer's disease, occurring years before enough nerve cells are choked off
to cause disability and death. The USF researchers were trying to determine what triggers
this early memory loss if neurons and their connections are still intact.
They used a technique known as microarray
analysis to simultaneously screen thousands of genes from brain tissue of mice bred to develop
Alzheimer's-associated amyloid plaques. A second more specific technique, quantatitive reverse
transcriptase polymerase chain reaction, confirmed the study results.
Six of at least 30 known genes associated
with memory and learning were dramatically reduced, or down-regulated, in the mouse model
for Alzheimer's disease when compared to the control mice with normal memory. Furthermore,
in the mouse model these six genes were signficantly decreased in regions of the brain containing
amyloid, the hippocampus and cerebral cortex, but remained unchanged in amyloid-free regions
of the brain.
The researchers then compared their findings
in the mouse model with an analysis of human Alzheimer's disease tissue from the Brain Donation
Program at Sun Health Research Institute in Sun City, AZ.
The same six memory-associated genes reduced
in the mousel model for Alzheimer's -- Arc, Zif268, NR2B, GluR1, Homer-1a and Nur77/TR3 --
were also significantly underexpressed in the amyloid-containing regions of brains from deceased
Alzheimer's patients. In the the amyloid-free regions of the human brains, the genes again
remained unchanged.
Furthermore in the human brains, unlike
the mouse brains, all genes related to neural activity were reduced, likely because the human
tissue was littered with dead nerve cells characteristic of late-stage Alzheimer's disease,
Dr. Morgan said.
The collective evidence strongly suggests
that the start of amyloid deposits in the brain selectively reduces expression of a group
of genes highly sensitive to amyloid and essential for forming new memories.
"Whether this change results in the
neural death leading to Alzheimer's disease remains to be seen," Dr. Morgan said.
About the Author... In addition to Dr. Morgan,
investigators were first author Chad Dickey, PhD, and Marcia Gordon, PhD, both from the USF
Alzheimer's Disease Research Laboratory; and Jeanne Loring, PhD; Julia Montgomery, PhD; and
P. Scott Eastman, PhD, all of Incyte Genomics Inc. in Palo Alto, CA.
Source: University of South Florida Health (Eureka
Alert)
Related Web Resources:
Study
Identifies Protein that Impairs Memory in Model for Alzheimer's Disease
Alzheimer's
Disease
Alzheimers
may 'seed' itself like mad cow disease
Alzheimer's
plaques revealed in living brains
also
see -> Senior
Health | Living
Wills & Advance Directives
Alzheimer's
& Diet
|